Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Hester Biosciences Limited (HBL) is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains.
Source: Wikipedia
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #80 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 5 Sep 2025 | RAJIV DINESH GANDHI | Promoter | Buy | 0 | ₹0 |
| 5 Sep 2025 | BHUPENDRA VITHALDAS GANDHI | Promoter | Sell | 0 | ₹0 |
| 8 Feb 2023 | SHAILA BHUPENDRA GANDHI | Promoter | Buy | 0 | ₹0 |
| 8 Feb 2023 | BHUPENDRA VITHALDAS GANDHI HUF | Promoter | Sell | 0 | ₹0 |
| 1 Jan 2021 | Bhupendra Vittaldas Gandhi HUF | Promoter | Sell | 0 | ₹0 |
| 1 Jan 2021 | SANJIV DINESH GANDHI | Promoter | Sell | 0 | ₹0 |
| 1 Jan 2021 | BHUPENDRA VITTALDAS GANDHI HUF | Promoter | Sell | 0 | ₹0 |
| 1 Jan 2021 | RAJIV DINESH GANDHI | Promoter | Buy | 0 | ₹0 |
| 1 Jan 2021 | BHUPENDRA VITTALDAS GANDHI HUF | Promoter | Sell | 0 | ₹0 |
| 1 Jan 2021 | Bhupendra Vittaldas Gandhi HUF | Promoter | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 22 Mar 2017 | RAJIV DINESH GANDHI | Block | Buy | 90,000 | 732.1000 | BSE |
| 22 Mar 2017 | HESTER COATINGS PRIVATE LIMITED | Block | Sell | 90,000 | 732.1000 | BSE |
| 22 Mar 2017 | HESTER COATINGS PRIVATE LIMITED | Bulk | Sell | 90,000 | 732.1000 | BSE |
| 22 Mar 2017 | RAJIV DINESH GANDHI | Bulk | Buy | 90,000 | 732.1000 | BSE |
| 21 Aug 2014 | K PAL JOY | Bulk | Sell | 47,800 | 276.0000 | BSE |
| 1 Jul 2014 | SHIRIN DHUNJISHAW GHANDHI | Bulk | Sell | 60,000 | 171.8000 | BSE |
| 24 Jun 2013 | PIYUSH BATUKBHAI DAVE | Bulk | Buy | 50,000 | 110.2300 | BSE |
| 24 Jun 2013 | PIYUSH BATUKBHAI DAVE | Bulk | Sell | 50,000 | 110.6700 | BSE |
| 22 Aug 2012 | JASHWANT JAGMOHAN SHAH | Bulk | Sell | 28,505 | 126.0000 | BSE |
| 22 Aug 2012 | VIRAJBEN SIDDHARTHBHAI PATEL | Bulk | Buy | 28,505 | 126.0000 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 14 Jul 2026 | Dividend - Rs 11 Per Share | 11.0000 | 14 Jul 2026 |
| 6 Aug 2025 | Dividend - Rs 7 Per Share | 7.0000 | 6 Aug 2025 |
| 22 Aug 2024 | Dividend - Rs 6 Per Share | 6.0000 | 22 Aug 2024 |
| 13 Sep 2023 | Annual General Meeting/Dividend - Rs 8 Per Share | 8.0000 | — |
| 11 Aug 2022 | Annual General Meeting/Dividend - Rs 10 Per Share | 10.0000 | — |
| 5 Aug 2021 | Dividend - Rs 10 Per Share | 10.0000 | — |
| 27 Aug 2020 | Dividend - Rs 6.60 Per Share | 6.6000 | — |
| 18 Jul 2019 | Dividend - Rs 7 Per Share | 7.0000 | — |
| 9 Nov 2018 | Interim Dividend - Rs 2 Per Sh | 2.0000 | 12 Nov 2018 |
| 30 Aug 2018 | Interim Dividend Rs 2 Per Share | 2.0000 | 31 Aug 2018 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Hester Pharmaceuticals Limited to Hester Biosciences Limited |
| 22 Aug 2024 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 30 Jul 2026 | Financial Results | Yes |
| 30 Jan 2026 | Financial Results | Yes |
| 12 Nov 2025 | Financial Results | Yes |
| 4 Nov 2025 | Financial Results | Yes |
| 1 Aug 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
